Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?
Introduction: The use of the fixed-dose combination of tramadol/dexketoprofen in Spain and in other countries has increased considerably. The authorized therapeutic indication for this medicinal product is the short-term symptomatic treatment of moderate to severe acute pain in adult patients. The...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Fundación Pharmaceutical Care España
2022-06-01
|
| Colección: | Pharmaceutical Care España |
| Materias: | |
| Acceso en línea: | https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/680 |